The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups. - Wikidata - wikimedia - TriplyDB

The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups.

The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups.

http://www.wikidata.org/entity/Q37195789

about

Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?

P2860

Q55064633-07F59A5A-8C5A-4473-BB6C-AAD42A037544

P2860

The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups.

http://www.wikidata.org/entity/Q37195789

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Comparison of Stereotactic ...... te Cancer by NCCN Risk Groups.

@en

The Comparison of Stereotactic ...... te Cancer by NCCN Risk Groups.

@nl

type

label

The Comparison of Stereotactic ...... te Cancer by NCCN Risk Groups.

@en

The Comparison of Stereotactic ...... te Cancer by NCCN Risk Groups.

@nl

prefLabel

The Comparison of Stereotactic ...... te Cancer by NCCN Risk Groups.

@en

The Comparison of Stereotactic ...... te Cancer by NCCN Risk Groups.

@nl

P1433

Q37195789-766E4B5E-8C27-40F6-9381-3AA29804A196

P1476

Q37195789-3B65D246-6AB1-4FAF-959C-E108DE041EC1

P2093

Q37195789-02E66FDB-6CDB-465F-B7FD-61F7EBB98057

Q37195789-0CA03611-A573-483E-B41B-E8646B6964A6

Q37195789-431C66C7-DCEF-4C4D-9D42-D405920A0B27

Q37195789-6B763DDD-D65F-4AF0-ACF3-DCE97CCCFA65

Q37195789-8976F0F8-DC11-4F11-B180-52FF3D48B900

Q37195789-89F739EA-ECA6-445C-A113-B454FE3C2A4D

Q37195789-8D299411-8EFA-4C03-9E10-53F44DC241A4

Q37195789-9AA54A0E-5646-430E-BBD7-BA2658316342

Q37195789-BF2B8478-8925-4161-941A-6B2723F20CD9

Q37195789-C80B6E58-0CC0-4321-B4FE-2FB91318C92D

P2860

Q37195789-04EA1D4E-7B14-40E7-92B6-B0A2872DD2BB

Q37195789-093E9A6F-FF5A-4717-B329-D6AFC7111A1A

Q37195789-0A8DD1ED-B11A-4748-BDBE-1A38D3351C38

Q37195789-122848BF-9F31-4A66-814E-2D4980C676EC

Q37195789-150B96B8-C641-400A-AAF2-0247A74307E8

Q37195789-1A750967-7B6A-4D73-9304-4E648D3B40CB

Q37195789-331851F3-A4FB-4420-83AB-2C0D9204EB0B

Q37195789-3893272C-C2DE-4AB6-81E0-B8C873763C44

Q37195789-549C5E5B-71DD-4DEC-B45A-0F4D6B364207

Q37195789-68F7C006-6040-490F-B097-535CB9399C72

P304

Q37195789-0649CE70-4C25-43BC-9AAF-B91DAA7B60F8

P31

Q37195789-392E41EB-6EA8-4B21-A0D0-7BC3D5D14252

P356

Q37195789-B3131C11-D763-4C55-A012-A9C9805D48B8

P478

Q37195789-F9C456D2-8E6C-40F8-9122-9BB9631C923C

P577

Q37195789-44166240-3DF3-4634-8625-D4033BD0C306

P698

Q37195789-9BE81FBE-CCA1-4CC2-988D-F8E80E027792

P921

Q37195789-66678731-EAA8-4EC1-BE0B-BEDA791582D3

P932

Q37195789-B31BE64C-40CB-4947-A465-7A8446046837

P356

FONC.2016.00184

P1433

Frontiers in Oncology

P1476

The Comparison of Stereotactic ...... te Cancer by NCCN Risk Groups.

@en

P2093

Alexandra Hanlon

http://www.w3.org/2001/XMLSchema#string

Anthony Ricco

http://www.w3.org/2001/XMLSchema#string

Bruce Garber

http://www.w3.org/2001/XMLSchema#string

Genevieve Manahan

http://www.w3.org/2001/XMLSchema#string

Jing Feng

http://www.w3.org/2001/XMLSchema#string

John Lamond

http://www.w3.org/2001/XMLSchema#string

Jun Yang

http://www.w3.org/2001/XMLSchema#string

Luther Brady

http://www.w3.org/2001/XMLSchema#string

Michael Mooreville

http://www.w3.org/2001/XMLSchema#string

Rachelle Lanciano

http://www.w3.org/2001/XMLSchema#string

P2860

The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy

Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base.

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines.

Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study

Cost implications of the rapid adoption of newer technologies for treating prostate cancer

Multi-institutional registry for prostate cancer radiosurgery: a prospective observational clinical trial.

P304

184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2016.00184

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27602330

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4994110

http://www.w3.org/2001/XMLSchema#string